Latest Stories
POST Q3 Deep Dive: Foodservice Growth Offsets Retail Volume Pressures, Guidance Cautious on Margins
Packaged foods company Post (NYSE:POST) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11.8% year on year to $2.25 billion. Its non-GAAP profit of $2.09 per share was 11.4% above analysts’ consensus estimates.
Q3 Earnings Roundup: Sea (NYSE:SE) And The Rest Of The Online Marketplace Segment
Let’s dig into the relative performance of Sea (NYSE:SE) and its peers as we unravel the now-completed Q3 online marketplace earnings season.
Q3 Earnings Highs And Lows: Accel Entertainment (NYSE:ACEL) Vs The Rest Of The Gaming Solutions Stocks
Let’s dig into the relative performance of Accel Entertainment (NYSE:ACEL) and its peers as we unravel the now-completed Q3 gaming solutions earnings season.
Q3 Earnings Highlights: Rivian (NASDAQ:RIVN) Vs The Rest Of The Automobile Manufacturing Stocks
Looking back on automobile manufacturing stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Rivian (NASDAQ:RIVN) and its peers.
Medical Devices & Supplies - Diversified Stocks Q3 Results: Benchmarking Stryker (NYSE:SYK)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Stryker (NYSE:SYK) and its peers.
Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Supernus Pharmaceuticals (NASDAQ:SUPN) and the best and worst performers in the branded pharmaceuticals industry.
VEEV Q3 Deep Dive: CRM Transitions and AI Progress Shape Mixed Market Response
Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 16% year on year to $811.2 million. Guidance for next quarter’s revenue was better than expected at $808.5 million at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $2.04 per share was 4.5% above analysts’ consensus estimates.
2 Cash-Heavy Stocks with Competitive Advantages and 1 We Find Risky
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
1 Insurance Stock to Consider Right Now and 2 That Underwhelm
Insurance firms play a critical role in the financial system, offering everything from property coverage to life insurance and specialized risk solutions. Still, investors are uneasy as insurers face challenges from catastrophic events and potential regulatory changes. These doubts have certainly contributed to insurance stocks’ recent underperformance - over the past six months, the industry’s 1.7% gain has fallen behind the S&P 500’s 12% rise.
1 Profitable Stock to Target This Week and 2 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".